Funder: la Caixa Foundation
Due Dates (Anticipated): February 2027 (Application deadline)
Funding Amounts: Stage 1: up to €50,000 for 12 months | Stage 2: up to €150,000 for 24 months | Stage 3: up to €500,000 for 24 months
Summary: Funding, mentoring and training help biomedical research teams validate assets and develop new life sciences products, services and businesses.
Key Information: Applicants must own or co-own the assets, with more than 50% held collectively by eligible public-sector or nonprofit institutions.
Description
The CaixaImpulse Health Innovation Programme, run by la Caixa Foundation with strategic collaborator Criteria Bio Ventures, helps transfer biomedical research into products, services and businesses that benefit society. It addresses the funding gap between early research support and later private investment, combining grants with mentoring, specialist advice and business training.
The programme supports human-health innovations in therapeutics, medical devices, diagnostics and digital health. Its three stages cover proof of concept, asset validation and prototype refinement, and advanced development toward regulatory filing and commercialisation. Projects should address an unmet need and identify feasible milestones toward market transfer. Teams may enter at any stage suited to their asset’s maturity and compete to advance after achieving their milestones.
